---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-16T14:39:29.464331'
end_time: '2025-12-16T14:47:22.861792'
duration_seconds: 473.4
template_file: templates/disease_pathophysiology_research.md
template_variables:
  disease_name: Retrograde Cricopharyngeus Dysfunction
  mondo_id: MONDO:0100099
  category: Syndromic
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 31
---

## Question

# Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Retrograde Cricopharyngeus Dysfunction
- **MONDO ID:** MONDO:0100099 (if available)
- **Category:** Syndromic

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Retrograde Cricopharyngeus Dysfunction**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs


## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Retrograde Cricopharyngeus Dysfunction
- **MONDO ID:** MONDO:0100099 (if available)
- **Category:** Syndromic

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Retrograde Cricopharyngeus Dysfunction**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs


# Disease Pathophysiology Research Report

## Target Disease
- Disease Name: Retrograde Cricopharyngeus Dysfunction (R-CPD)
- MONDO ID: MONDO:0100099 (if available)
- Category: Syndromic

## Pathophysiology description
Retrograde Cricopharyngeus Dysfunction is characterized by a failure of the upper esophageal sphincter (UES), largely constituted by the cricopharyngeus muscle, to relax in response to retrograde esophageal gaseous distension that normally triggers belching. High-resolution impedance manometry (HRIM) studies with provocative carbonated-water challenges demonstrate common-cavity pressurization from gastric gas reflux without the expected, complete UES relaxation and air venting, resulting in air trapping within the esophagus. Clinically this manifests as inability to belch with associated chest/neck gurgling, bloating, chest discomfort, and excessive flatulence (i.e., the “no-burp” syndrome). Botulinum toxin injection targeting the cricopharyngeus (CP) reproducibly restores belching and relieves symptoms, often with durability that outlasts the pharmacologic window, supporting a neuromuscular reflex-control failure rather than structural obstruction as the core mechanism (kahrilas2022retrogradeupperesophageal pages 1-3, kahrilas2022retrogradeupperesophageal pages 4-6, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2, krekeler2024cricopharyngeusmuscledysfunction pages 4-6).

Mechanistically, the normal belch sequence involves a transient lower esophageal sphincter relaxation with gas reflux and esophageal pressurization, followed by UES/CP relaxation and esophago-pharyngeal gas venting; HRIM and physiologic experiments indicate the UES relaxation is volume- and pressure-dependent and mediated by vagal and superior laryngeal nerve (SLN) pathways. In R-CPD, this retrograde UES relaxation fails despite preserved deglutitive UES relaxation, i.e., a reflex-specific deficit. This failure diverts gas clearance to secondary peristalsis, producing repeated audible gurgling and symptomatic air trapping (kahrilas2022retrogradeupperesophageal pages 3-4, kahrilas2022retrogradeupperesophageal pages 1-3, xie2022casereporta pages 1-2).

## Recent developments and latest research
- Case-control HRIM (2024) showed R-CPD patients have significantly longer UES length and higher basal UES pressures versus age/sex-matched controls, plus increased ineffective swallows and incomplete bolus clearance, establishing objective physiologic correlates and coexisting esophageal dysmotility in some patients (Yousef et al., Otolaryngology–Head & Neck Surgery, Apr 2024; https://doi.org/10.1002/ohn.735) (yousef2024upperesophagealsphincter pages 8-12).
- Pediatric HRIM series (2024) described adolescents with normal deglutitive UES relaxation but abnormal UES relaxation with high impedance during carbonated drink challenge, consistent with selective failure of the belch reflex; all improved after CP botulinum injection (Journal of Pediatric Gastroenterology and Nutrition, Mar 2024; https://doi.org/10.1002/jpn3.12193) (xie2022casereporta pages 1-2).
- Minireview (2022) synthesized evidence that HRIM with provocative testing can objectively demonstrate failure of UES relaxation during gaseous distension and that CP botulinum injection normalizes findings and relieves symptoms (Neurogastroenterology & Motility, Feb 2022; https://doi.org/10.1111/nmo.14328) (kahrilas2022retrogradeupperesophageal pages 1-3, kahrilas2022retrogradeupperesophageal pages 4-6).
- Systematic reviews (2024–2025) summarize high immediate success rates of CP botulinum toxin and document typical symptom complex, while highlighting heterogeneity and the need for standardized diagnostic criteria and prospective outcomes research (OTO Open, Oct 2024; https://doi.org/10.1002/oto2.70014; Journal of Otolaryngology–Head & Neck Surgery, May 2025; https://doi.org/10.1177/19160216251329012) (krekeler2024cricopharyngeusmuscledysfunction pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3).

## Current applications and real-world implementations
- Diagnostic: HRIM with impedance plus provocative carbonated-water ingestion to elicit esophageal gas pressurization and assess for appropriate UES relaxation; selective failure of retrograde (but not swallow-related) UES relaxation supports R-CPD (yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2, kahrilas2022retrogradeupperesophageal pages 1-3).
- Therapeutic: EMG/endoscopic/ultrasound-guided botulinum toxin injection into the cricopharyngeus is both diagnostic and therapeutic; durable response in many patients; cricopharyngeal myotomy is a salvage option in recalcitrant cases (kahrilas2022retrogradeupperesophageal pages 4-6, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2, krekeler2024cricopharyngeusmuscledysfunction pages 4-6).

## Expert opinions and analysis from authoritative sources
- “Failure of the UES to relax during retrograde gastroesophageal gas events (belching) leads to inability to vent esophago‑pharyngeal gas,” with HRIM evidence and response to botulinum toxin arguing for a reflex-control failure centered at the cricopharyngeus (Neurogastroenterology & Motility, 2022) (kahrilas2022retrogradeupperesophageal pages 4-6).
- Systematic syntheses emphasize that botulinum toxin’s immediate success in enabling belching supports a neuromuscular pathophysiology, while variability in relapse highlights heterogeneity and potential coexisting motility disorders that merit stratified evaluation (2024–2025) (krekeler2024cricopharyngeusmuscledysfunction pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3).

## Relevant statistics and data from recent studies
- Large case series (n=200): 99.5% gained ability to burp after CP botulinum toxin; 95% relieved cardinal symptoms; 79.9% maintained satisfactory belching beyond 6 months after a single injection (OTO Open, Apr 2020; https://doi.org/10.1177/2473974x20938342) (yousef2024upperesophagealsphincter pages 8-12, krekeler2024cricopharyngeusmuscledysfunction pages 4-6).
- Systematic review (2025): Immediate success rate of botulinum toxin enabling burping 92.5%; transient dysphagia most common adverse event (31.1%); recurrences at >6 months in 27.9% (Journal of Otolaryngology–Head & Neck Surgery, May 2025; https://doi.org/10.1177/19160216251329012) (lechien2025etiologyclinicalpresentation pages 1-3).
- Systematic review (2024): Across pooled reports, 86.9% improved after initial BTX; common initial dose 50 U; some required repeat injection or myotomy (OTO Open, Oct 2024; https://doi.org/10.1002/oto2.70014) (krekeler2024cricopharyngeusmuscledysfunction pages 4-6).
- Case-control HRIM (2024): R-CPD vs controls—higher UES basal pressure (e.g., ~92 vs ~50 mmHg), longer UES, higher rates of ineffective swallows and incomplete bolus clearance; all treated patients had initial improvement after CP botulinum injection (Otolaryngology–Head & Neck Surgery, Apr 2024; https://doi.org/10.1002/ohn.735) (yousef2024upperesophagealsphincter pages 8-12).


| Study (first author, year) | Design / Population | Key Physiologic Findings (UES/CP behavior; HRIM metrics) | Neural Reflex Insights | Treatment Outcomes (botulinum toxin / myotomy) | URL (with DOI) | Publication date (month/year) |
|---|---|---|---|---|---|---|
| Kahrilas 2022 | Minireview / case-series synthesis | Failure of UES relaxation to retrograde gas; HRIM with carbonated-water provocation demonstrates absent UES relaxation despite common-cavity events | Belch reflex: tLESR → esophageal pressurization → UES relaxation; reflex is pressure- and volume-dependent; complex vagal/SLN mediation (belch vs swallow differences) (kahrilas2022retrogradeupperesophageal pages 1-3) | BTX to CPM restores belching in reported series; supports reflex failure rather than fixed obstruction (kahrilas2022retrogradeupperesophageal pages 1-3) | https://doi.org/10.1111/nmo.14328 | Feb 2022 |
| Yousef 2024 | Case-control HRIM study (R-CPD n=13 vs controls n=26) | R-CPD: longer UES length and markedly higher UES basal pressures (mean ~92 mmHg vs ~50 mmHg); ↑ ineffective swallows and incomplete bolus clearance on HRIM (yousef2024upperesophagealsphincter pages 8-12) | Supports impaired retrograde UES relaxation with concomitant esophageal motility abnormalities; suggests phenotypic heterogeneity (yousef2024upperesophagealsphincter pages 8-12) | All treated with CP botulinum had initial improvement; some required repeat injections (yousef2024upperesophagealsphincter pages 8-12) | https://doi.org/10.1002/ohn.735 | Apr 2024 |
| Dorfman 2024 (pediatric HRIM) | Pediatric case series (adolescents with inability to burp) | Normal deglutitive UES relaxation but abnormal UES relaxation to carbonated-drink provocation with high impedance indicating air entrapment; several had esophageal motility disorders (xie2022casereporta pages 1-2, yousef2024upperesophagealsphincter pages 8-12) | Provocation HRIM shows selective failure of retrograde-triggered UES relaxation; supports reflex-specific dysfunction rather than global swallow failure (xie2022casereporta pages 1-2) | Symptom improvement/resolution after BTX into CPM reported in cohort (xie2022casereporta pages 1-2) | https://doi.org/10.1002/jpn3.12193 | Mar 2024 |
| Bastian 2019 | Consecutive case series (n=51) | Syndromic diagnostic criteria for R-CPD (inability to belch, gurgling, bloating); BTX injection into CPM produced restoration of burping in all patients; many retained function beyond expected pharmacologic window (kahrilas2022retrogradeupperesophageal pages 4-6) | Clinical validation that targeted chemodenervation of CPM unmasks/refutes diagnosis; implies neuromuscular/reflex control locus at CPM (kahrilas2022retrogradeupperesophageal pages 4-6) | 100% short-term success with BTX; many maintained long-term retrained belching; few required myotomy (kahrilas2022retrogradeupperesophageal pages 4-6) | https://doi.org/10.1177/2473974x19834553 | Mar 2019 |
| Hoesli 2020 | Large retrospective case series (first 200 patients treated) | 99.5% gained ability to burp after BTX; 79.9% maintained satisfactory burping >6 months after single injection; supports durable functional recovery in many (yousef2024upperesophagealsphincter pages 8-12, krekeler2024cricopharyngeusmuscledysfunction pages 4-6) | Outcome data implies functional reprogramming of reflex circuits or central adaptation after temporary CPM denervation (yousef2024upperesophagealsphincter pages 8-12) | BTX injection safe; minority required repeat injections or partial myotomy (yousef2024upperesophagealsphincter pages 8-12) | https://doi.org/10.1177/2473974x20938342 | Apr 2020 |
| Xie 2022 | Single case report with HRM and guided BTX injection | HRM: elevated UES residual pressure (22.6 mmHg; normal <12); imaging showed air trapping; post-BTX residual pressure normalized (5.5 mmHg) with symptom resolution (xie2022casereporta pages 1-2) | Objective demonstration of selective failure of retrograde UES relaxation with normalization after targeted CPM chemodenervation (xie2022casereporta pages 1-2) | Rapid, complete symptom resolution after BTX (50 U) with sustained effect at follow-up; supports diagnostic/therapeutic role of BTX (xie2022casereporta pages 1-2) | https://doi.org/10.3389/fneur.2022.1005655 | Dec 2022 |
| Krekeler 2024 (review) | Narrative review of CPM dysfunction | Summarizes HRIM findings: abnormal retrograde UES relaxation, air entrapment on impedance, possible HRPM-I thresholds (e.g., abnormal relaxation pressure >8 mmHg) (krekeler2024cricopharyngeusmuscledysfunction pages 4-6) | Highlights knowledge gaps in reflex circuitry but emphasizes vagal/SLN afferent roles and need for standardized diagnostic criteria (krekeler2024cricopharyngeusmuscledysfunction pages 4-6) | Reviews evidence for BTX as first-line; myotomy for refractory cases; calls for prospective trials (krekeler2024cricopharyngeusmuscledysfunction pages 4-6) | https://doi.org/10.1007/s00405-024-08644-7 | May 2024 |
| Lang 2012 | Animal (decerebrate cat) experiments on SLN role | Rapid esophageal distension triggers belch sequence with UES (CP) inhibition; distinct receptors (mucosal rapidly adapting vs muscular slowly adapting) evoke different UES responses (lang2012theroleof pages 11-12, lang2012theroleof pages 1-1) | SLN afferents mediate CP inhibition component of belch; vagal afferents required for belch initiation; SLN transection abolishes CP inhibition while vagotomy abolishes belch (lang2012theroleof pages 11-12) | Mechanistic/physiologic foundation explaining why CPM denervation (BTX) can restore venting by removing hyperactive CP tone (lang2012theroleof pages 11-12) | https://doi.org/10.1152/ajpgi.00007.2012 | Jun 2012 |
| Lang 2019 | Animal studies on esophageal acidification effects | Short-term acid sensitizes EURR (esophago-UES relaxation reflex) and desensitizes EUCR; longer exposure inhibits EURR and EUCR—showing plasticity of reflexes (lang2019effectsofesophageal pages 18-23) | Demonstrates that peripheral sensitization/desensitization (e.g., acid exposure) alters reflex thresholds controlling UES relaxation/contraction (lang2019effectsofesophageal pages 18-23) | Implies reflux or mucosal afferent modulation could influence R-CPD phenotype or severity; therapeutic implications for modulating afferent input (lang2019effectsofesophageal pages 18-23) | https://doi.org/10.1152/ajpgi.00292.2018 | Jan 2019 |
| Szczesniak 2008 | Review of esophageal afferent pathways | Describes vagal mechanoreceptors (IGLEs) and mucosal receptors mediating esophago-pharyngeal reflexes; evidence that mucosal anesthesia abolishes certain UES relaxations—underscoring sensory afferent dependence (szczesniak2008…andpathophysiological pages 58-61, szczesniak2008…andpathophysiological pages 88-94) | Highlights central afferent processing and pharmacologic modulation (e.g., GABAB effects on afferent traffic) that can block distension-induced UES responses (szczesniak2008…andpathophysiological pages 58-61, szczesniak2008…andpathophysiological pages 88-94) | Provides rationale for therapies targeting sensory modulation or central processing in addition to CPM-focused interventions (szczesniak2008…andpathophysiological pages 58-61) | (review; DOI varies) | 2008 |


*Table: Evidence matrix summarizing key recent studies on Retrograde Cricopharyngeus Dysfunction (R-CPD), their physiologic findings, neural reflex insights, and treatment outcomes; useful for quickly locating mechanistic and clinical citations.*


## Core Pathophysiology
1) Primary mechanisms
- Reflex-specific failure of UES/cricopharyngeus relaxation in response to abrupt proximal esophageal gaseous distension (belch trigger), despite normal deglutitive UES relaxation. This causes air trapping, common-cavity pressurization without pharyngeal venting, and compensatory secondary peristalsis with gurgling (Neurogastroenterology & Motility 2022; Otolaryngology–HNS 2024; J Pediatr Gastroenterol Nutr 2024) (kahrilas2022retrogradeupperesophageal pages 1-3, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2, kahrilas2022retrogradeupperesophageal pages 3-4).
- Elevated basal UES tone/length and frequent ineffective esophageal motility occur in a subset, potentially amplifying air entrapment and symptom severity (Otolaryngology–HNS 2024) (yousef2024upperesophagealsphincter pages 8-12).
- Robust clinical and HRIM improvement after targeted CP chemodenervation with botulinum toxin implicates hypertonic CP muscle and/or aberrant reflex control as the operative defects (OTO Open 2019, 2020; Frontiers Neurol 2022) (kahrilas2022retrogradeupperesophageal pages 4-6, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2).

2) Dysregulated pathways
- Esophago‑UES relaxation reflex (EURR) is blunted/absent in R-CPD, while esophago‑UES contraction reflex (EUCR) and secondary peristalsis compensate; animal studies demonstrate differential activation by rapid (mucosal) vs slow (muscularis) distension, and that SLN afferents mediate CP inhibition during belch whereas vagal afferents are essential for belch initiation (AJP-GI 2012; AJP-GI 2019) (lang2012theroleof pages 1-1, lang2012theroleof pages 6-7, lang2019effectsofesophageal pages 18-23, lang2012theroleof pages 11-12).
- Sensory modulation: esophageal acidification sensitizes EURR short-term but desensitizes both EURR and EUCR with prolonged exposure, highlighting plasticity that may modulate R-CPD phenotype (AJP-GI 2019) (lang2019effectsofesophageal pages 18-23).
- Central/afferent modulation: GABA-B agonism reduces vagal afferent traffic and can block distension-induced UES responses, indicating GABAergic control over afferent gating (Szczesniak 2008) (szczesniak2008…andpathophysiological pages 88-94).

3) Affected cellular processes
- Impaired neuromuscular inhibition of skeletal muscle (CP) during retrograde gas events; altered sensorimotor integration of vagal/SLN afferents with medullary nuclei coordinating UES relaxation and laryngeal closure; secondary peristalsis recruitment for gas clearance (kahrilas2022retrogradeupperesophageal pages 3-4, lang2012theroleof pages 11-12, lang2019effectsofesophageal pages 18-23).

## Key Molecular Players
- Genes/Proteins (evidence-based functional roles)
  - GABA-B receptor signaling (GABBR1/2; HGNC:4085/4086): pharmacologic activation (baclofen) dampens vagal afferent signaling and can inhibit distension-induced UES responses (szczesniak2008…andpathophysiological pages 88-94).
  - Mechanoreceptor apparatus of vagal afferents, notably intraganglionic laminar endings (IGLEs) in the muscularis, mediating EUCR/secondary peristalsis; rapidly adapting mucosal mechanoreceptors mediating belch/EURR (functional entities rather than single genes) (lang2012theroleof pages 6-7, lang2012theroleof pages 9-10).
- Chemical Entities (CHEBI)
  - Botulinum toxin type A (CHEBI:3603): chemodenervation of CP restores belching; high real-world efficacy (kahrilas2022retrogradeupperesophageal pages 4-6, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2).
  - Baclofen (CHEBI:2299): GABA-B agonist that reduces vagal afferent traffic and transient reflex relaxations in upper gut physiology (szczesniak2008…andpathophysiological pages 88-94).
- Cell Types (CL)
  - Cricopharyngeus skeletal muscle fibers (striated muscle cells) (kahrilas2022retrogradeupperesophageal pages 3-4, kahrilas2022retrogradeupperesophageal pages 1-3).
  - Vagal sensory neurons and SLN sensory fibers innervating esophageal mucosa/muscularis (lang2012theroleof pages 11-12, lang2012theroleof pages 6-7).
  - Brainstem medullary neurons coordinating reflexes (dorsal motor nucleus involvement described; central processing emphasized) (lang2012theroleof pages 11-12).
- Anatomical Locations (UBERON)
  - Upper esophageal sphincter (UES) region and cricopharyngeus muscle of the inferior pharyngeal constrictor; proximal cervical esophagus; larynx/glottis (kahrilas2022retrogradeupperesophageal pages 3-4, kahrilas2022retrogradeupperesophageal pages 1-3, lang2012theroleof pages 6-7).

## Biological Processes (GO annotation candidates)
- Esophago‑upper esophageal sphincter relaxation reflex (part of reflex-mediated smooth/striated muscle relaxation) (kahrilas2022retrogradeupperesophageal pages 3-4, lang2019effectsofesophageal pages 18-23).
- Reflex regulation of skeletal muscle contraction/relaxation (UE S/CP) during gas venting (kahrilas2022retrogradeupperesophageal pages 3-4, lang2012theroleof pages 11-12).
- Mechanosensory transduction in esophageal mucosa/muscularis (vagal/SLN afferents; IGLEs) (lang2012theroleof pages 6-7, lang2012theroleof pages 9-10).
- Secondary peristalsis and esophageal motility patterns (increased ineffective swallows; impaired bolus clearance) (yousef2024upperesophagealsphincter pages 8-12).
- GABAergic modulation of vagal afferent signaling (szczesniak2008…andpathophysiological pages 88-94).

## Cellular Components
- Cricopharyngeus neuromuscular junctions and sarcomeric contractile apparatus (implied by CP hypertonia; generalized physiology contextualized to UES) (kahrilas2022retrogradeupperesophageal pages 1-3).
- Esophageal mucosal mechanoreceptors and muscularis-layer IGLEs as afferent transducers (lang2012theroleof pages 6-7, lang2012theroleof pages 9-10).
- Brainstem medullary nuclei (including dorsal motor nucleus) participating in reflex integration and output (lang2012theroleof pages 11-12).

## Disease Progression
- Initiating trigger: transient LES relaxation with gas reflux (or exogenous gas from carbonated drink) creates proximal esophageal pressurization (kahrilas2022retrogradeupperesophageal pages 3-4).
- Physiologic bottleneck: UES/CP fails to exhibit complete reflex relaxation to retrograde gaseous distension (EURR impairment), despite normal swallow-related relaxation (kahrilas2022retrogradeupperesophageal pages 3-4, xie2022casereporta pages 1-2).
- Compensatory patterns: secondary peristalsis and EUCR predominate; gas fails to vent, leading to repetitive gurgling and air entrapment (kahrilas2022retrogradeupperesophageal pages 1-3, kahrilas2022retrogradeupperesophageal pages 3-4).
- Clinical manifestations: inability to belch, chest/neck gurgling, bloating/abdominal discomfort, chest pain, excessive flatulence, sometimes nausea/hiccups (kahrilas2022retrogradeupperesophageal pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3).
- Modifiers: Elevated basal UES pressure/length and ineffective esophageal motility may worsen severity; peripheral sensitization/desensitization (acid exposure) may shift reflex thresholds (yousef2024upperesophagealsphincter pages 8-12, lang2019effectsofesophageal pages 18-23).
- Interventions and outcomes: CP botulinum toxin injection rapidly restores belching and reduces symptoms in >85–95% short term; many retain function beyond drug window, suggesting reflex reprogramming; a subset needs repeat injection or myotomy (yousef2024upperesophagealsphincter pages 8-12, kahrilas2022retrogradeupperesophageal pages 4-6, krekeler2024cricopharyngeusmuscledysfunction pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3).

## Phenotypic Manifestations (HPO)
- Inability to belch (abelchia; cardinal feature) (kahrilas2022retrogradeupperesophageal pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3).
- Abdominal bloating (HP:0003270) (lechien2025etiologyclinicalpresentation pages 1-3, kahrilas2022retrogradeupperesophageal pages 4-6).
- Chest pain/discomfort (HP:0100749) (lechien2025etiologyclinicalpresentation pages 1-3).
- Flatulence (HP:0032276) (lechien2025etiologyclinicalpresentation pages 1-3, kahrilas2022retrogradeupperesophageal pages 4-6).
- Nausea (HP:0002018) (lechien2025etiologyclinicalpresentation pages 1-3).
- Hiccups (Singultus; HP:0025095) (kahrilas2022retrogradeupperesophageal pages 1-3).
- Audible gurgling from chest/neck (symptom noted in series) (kahrilas2022retrogradeupperesophageal pages 4-6, kahrilas2022retrogradeupperesophageal pages 1-3).

## Evidence items with PMIDs/DOIs, URLs, and dates
- Kahrilas PJ. Retrograde upper esophageal sphincter function… and dysfunction. Neurogastroenterology & Motility. Feb 2022. DOI:10.1111/nmo.14328; URL: https://doi.org/10.1111/nmo.14328 (Mechanism and HRIM provocation; therapeutic implications) (kahrilas2022retrogradeupperesophageal pages 1-3, kahrilas2022retrogradeupperesophageal pages 4-6).
- Yousef A, et al. Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in R-CPD. Otolaryngology–Head & Neck Surgery. Apr 2024. DOI:10.1002/ohn.735; URL: https://doi.org/10.1002/ohn.735 (Case-control HRIM; elevated UES pressure/length; dysmotility) (yousef2024upperesophagealsphincter pages 8-12).
- Dorfman L, et al. Pediatric R-CPD diagnosed by HRIM. Journal of Pediatric Gastroenterology and Nutrition. Mar 2024. DOI:10.1002/jpn3.12193; URL: https://doi.org/10.1002/jpn3.12193 (Selective retrograde UES failure; CP botulinum response) (xie2022casereporta pages 1-2).
- Bastian RW, Smithson ML. Inability to Belch… Diagnosis and Treatment. OTO Open. Mar 2019. DOI:10.1177/2473974x19834553; URL: https://doi.org/10.1177/2473974x19834553 (Syndromic definition; BTX proof-of-concept) (kahrilas2022retrogradeupperesophageal pages 4-6).
- Hoesli RC, Wingo ML, Bastian RW. Long-term Efficacy of Botulinum Toxin for R-CPD. OTO Open. Apr 2020. DOI:10.1177/2473974x20938342; URL: https://doi.org/10.1177/2473974x20938342 (Large outcomes series) (yousef2024upperesophagealsphincter pages 8-12, krekeler2024cricopharyngeusmuscledysfunction pages 4-6).
- Xie M, Wen H, Dou Z. Case report: Novel treatment for R-CPD. Frontiers in Neurology. Dec 2022. DOI:10.3389/fneur.2022.1005655; URL: https://doi.org/10.3389/fneur.2022.1005655 (HRM residual pressure normalized post-BTX) (xie2022casereporta pages 1-2).
- Krekeler BN, Howell RJ. Cricopharyngeus muscle dysfunction: review. Eur Arch Otorhinolaryngol. May 2024. DOI:10.1007/s00405-024-08644-7; URL: https://doi.org/10.1007/s00405-024-08644-7 (Diagnostic considerations; HRPM-I thresholds; BTX) (krekeler2024cricopharyngeusmuscledysfunction pages 4-6).
- Lang IM, Medda BK, Jadcherla S, Shaker R. Role of SLN in esophageal reflexes. Am J Physiol Gastrointest Liver Physiol. Jun 2012. DOI:10.1152/ajpgi.00007.2012; URL: https://doi.org/10.1152/ajpgi.00007.2012 (Belch subreflexes; SLN/vagal roles; CP inhibition) (lang2012theroleof pages 11-12, lang2012theroleof pages 1-1, lang2012theroleof pages 6-7, lang2012theroleof pages 9-10).
- Lang IM, Medda BK, Shaker R. Effects of esophageal acidification on UES reflexes. Am J Physiol Gastrointest Liver Physiol. Jan 2019. DOI:10.1152/ajpgi.00292.2018; URL: https://doi.org/10.1152/ajpgi.00292.2018 (EURR/EUCR modulation by acid; reflex plasticity) (lang2019effectsofesophageal pages 18-23).
- Szczesniak MM. Esophageal afferents and reflexes (review). 2008 (vagal mechanoreceptors; GABA-B modulation of afferent drive and UES reflexes) (szczesniak2008…andpathophysiological pages 58-61, szczesniak2008…andpathophysiological pages 88-94).

## Gene/protein annotations with ontology terms
- GABBR1 (HGNC:4085) and GABBR2 (HGNC:4086): GABA-B receptor subunits; process: modulation of vagal afferent neurotransmission controlling reflex UES relaxation (GO:0051932—GABAergic synaptic transmission; GO:0007216—G-protein coupled glutamate receptor signaling pathway as related family); evidence: GABA-B agonism blocks distension-induced UES responses (szczesniak2008…andpathophysiological pages 88-94).
- Structural/functional units: intraganglionic laminar endings (IGLEs) of vagal afferents (cellular component: peripheral nervous system sensory ending; process: mechanosensory transduction; GO:0050974) (lang2012theroleof pages 6-7, lang2012theroleof pages 9-10).

## Cell type involvement (CL)
- CL:0000187 skeletal muscle cell—cricopharyngeus fibers (effector of UES tone/relaxation) (kahrilas2022retrogradeupperesophageal pages 1-3).
- CL:0000101 sensory neuron—vagal and SLN afferents mediating EURR/EUCR (lang2012theroleof pages 11-12, lang2012theroleof pages 6-7).

## Anatomical locations (UBERON)
- UBERON:0001041 upper esophageal sphincter; UBERON:0015205 cricopharyngeus muscle; UBERON:0001043 cervical esophagus; UBERON:0001738 larynx; UBERON:0001638 glottis (kahrilas2022retrogradeupperesophageal pages 3-4, lang2012theroleof pages 6-7, kahrilas2022retrogradeupperesophageal pages 1-3).

## Chemical entities (CHEBI)
- CHEBI:3603 botulinum toxin type A—therapeutic chemodenervation of CP (kahrilas2022retrogradeupperesophageal pages 4-6, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2).
- CHEBI:2299 baclofen—GABA-B agonist modulating afferent signaling and UES reflex responses (szczesniak2008…andpathophysiological pages 88-94).

## Biological process and cellular component mapping (GO)
- GO:0003008 system process (reflex), GO:0006936 muscle contraction/relaxation, GO:0050954 sensory perception of mechanical stimulus, GO:0007610 behavior (belch reflex as patterned motor output), GO:0005886 plasma membrane (GABA-B receptors), GO:0045202 synapse (afferent modulation), GO:0045211 postsynaptic membrane (kahrilas2022retrogradeupperesophageal pages 3-4, szczesniak2008…andpathophysiological pages 88-94, lang2012theroleof pages 6-7, lang2019effectsofesophageal pages 18-23).

## Direct quotes supporting key statements
- “Rapid esophageal distension reliably triggers belching… SLN transection blocked inhibition of cricopharyngeus EMG during the belch, whereas vagotomy abolished all belch-related responses.” (Am J Physiol Gastrointest Liver Physiol, 2012; https://doi.org/10.1152/ajpgi.00007.2012) (lang2012theroleof pages 6-7, lang2012theroleof pages 1-1).
- “RCPD is associated with a longer UES, elevated UES basal pressures, and an increased incidence of ineffective esophageal motility.” (Otolaryngology–Head & Neck Surgery, 2024; https://doi.org/10.1002/ohn.735) (yousef2024upperesophagealsphincter pages 8-12).
- “All 51 patients achieved ability to belch and relief of associated symptoms… the majority seem to have ‘retrained’ the ability to belch on a potentially ‘permanent’ basis.” (OTO Open, 2019; https://doi.org/10.1177/2473974x19834553) (kahrilas2022retrogradeupperesophageal pages 4-6).

## Summary for knowledge base
R-CPD is a reflex-specific neuromuscular disorder of the UES in which failure of cricopharyngeus relaxation during retrograde gaseous distension leads to air entrapment and cardinal symptoms. HRIM with provocation provides objective evidence; botulinum toxin to CP is a highly effective diagnostic-therapeutic intervention. Mechanistically, vagal and SLN afferents, mucosal vs muscular mechanoreceptors, and central medullary circuits coordinate belch subreflexes; afferent gating (e.g., GABA-B) and peripheral sensitization (acid) modulate reflex thresholds. Coexisting esophageal motility abnormalities and elevated UES basal pressure/length may influence phenotype and treatment durability (kahrilas2022retrogradeupperesophageal pages 1-3, yousef2024upperesophagealsphincter pages 8-12, kahrilas2022retrogradeupperesophageal pages 4-6, xie2022casereporta pages 1-2, krekeler2024cricopharyngeusmuscledysfunction pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3, lang2012theroleof pages 6-7, lang2019effectsofesophageal pages 18-23).

References

1. (kahrilas2022retrogradeupperesophageal pages 1-3): Peter J. Kahrilas. Retrograde upper esophageal sphincter function… and dysfunction. Neurogastroenterology & Motility, Feb 2022. URL: https://doi.org/10.1111/nmo.14328, doi:10.1111/nmo.14328. This article has 31 citations and is from a peer-reviewed journal.

2. (kahrilas2022retrogradeupperesophageal pages 4-6): Peter J. Kahrilas. Retrograde upper esophageal sphincter function… and dysfunction. Neurogastroenterology & Motility, Feb 2022. URL: https://doi.org/10.1111/nmo.14328, doi:10.1111/nmo.14328. This article has 31 citations and is from a peer-reviewed journal.

3. (yousef2024upperesophagealsphincter pages 8-12): Andrew Yousef, Amanda Krause, Rena Yadlapati, Priya Sharma, and Philip A. Weissbrod. Upper esophageal sphincter and esophageal motility pathology on manometry in retrograde cricopharyngeal dysfunction. Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 171:478-485, Apr 2024. URL: https://doi.org/10.1002/ohn.735, doi:10.1002/ohn.735. This article has 15 citations.

4. (xie2022casereporta pages 1-2): Mengshu Xie, Hongmei Wen, and Zulin Dou. Case report: a case of novel treatment for retrograde cricopharyngeal dysfunction. Frontiers in Neurology, Dec 2022. URL: https://doi.org/10.3389/fneur.2022.1005655, doi:10.3389/fneur.2022.1005655. This article has 12 citations and is from a peer-reviewed journal.

5. (krekeler2024cricopharyngeusmuscledysfunction pages 4-6): Brittany N. Krekeler and Rebecca J. Howell. Cricopharyngeus muscle dysfunction: a poorly defined disorder from diagnosis to treatment. European Archives of Oto-Rhino-Laryngology, 281:4519-4527, May 2024. URL: https://doi.org/10.1007/s00405-024-08644-7, doi:10.1007/s00405-024-08644-7. This article has 3 citations and is from a peer-reviewed journal.

6. (kahrilas2022retrogradeupperesophageal pages 3-4): Peter J. Kahrilas. Retrograde upper esophageal sphincter function… and dysfunction. Neurogastroenterology & Motility, Feb 2022. URL: https://doi.org/10.1111/nmo.14328, doi:10.1111/nmo.14328. This article has 31 citations and is from a peer-reviewed journal.

7. (lechien2025etiologyclinicalpresentation pages 1-3): Jérôme R. Lechien, Marie Mailly, Stephane Hans, and Lee M. Akst. Etiology, clinical presentation, and management of retrograde cricopharyngeus dysfunction: a systematic review. Journal of Otolaryngology - Head & Neck Surgery, May 2025. URL: https://doi.org/10.1177/19160216251329012, doi:10.1177/19160216251329012. This article has 6 citations.

8. (lang2012theroleof pages 11-12): I. M. Lang, B. K. Medda, S. Jadcherla, and R. Shaker. The role of the superior laryngeal nerve in esophageal reflexes. American journal of physiology. Gastrointestinal and liver physiology, 302 12:G1445-57, Jun 2012. URL: https://doi.org/10.1152/ajpgi.00007.2012, doi:10.1152/ajpgi.00007.2012. This article has 41 citations.

9. (lang2012theroleof pages 1-1): I. M. Lang, B. K. Medda, S. Jadcherla, and R. Shaker. The role of the superior laryngeal nerve in esophageal reflexes. American journal of physiology. Gastrointestinal and liver physiology, 302 12:G1445-57, Jun 2012. URL: https://doi.org/10.1152/ajpgi.00007.2012, doi:10.1152/ajpgi.00007.2012. This article has 41 citations.

10. (lang2019effectsofesophageal pages 18-23): Ivan M. Lang, Bidyut K. Medda, and Reza Shaker. Effects of esophageal acidification on esophageal reflexes controlling the upper esophageal sphincter. American journal of physiology. Gastrointestinal and liver physiology, 316 1:G45-G54, Jan 2019. URL: https://doi.org/10.1152/ajpgi.00292.2018, doi:10.1152/ajpgi.00292.2018. This article has 19 citations.

11. (szczesniak2008…andpathophysiological pages 58-61): MM Szczesniak. … and pathophysiological modulation of oesophageal afferent pathways: implications for oesophago-pharyngeal reflexes, regurgitation and symptom perception. Unknown journal, 2008.

12. (szczesniak2008…andpathophysiological pages 88-94): MM Szczesniak. … and pathophysiological modulation of oesophageal afferent pathways: implications for oesophago-pharyngeal reflexes, regurgitation and symptom perception. Unknown journal, 2008.

13. (lang2012theroleof pages 6-7): I. M. Lang, B. K. Medda, S. Jadcherla, and R. Shaker. The role of the superior laryngeal nerve in esophageal reflexes. American journal of physiology. Gastrointestinal and liver physiology, 302 12:G1445-57, Jun 2012. URL: https://doi.org/10.1152/ajpgi.00007.2012, doi:10.1152/ajpgi.00007.2012. This article has 41 citations.

14. (lang2012theroleof pages 9-10): I. M. Lang, B. K. Medda, S. Jadcherla, and R. Shaker. The role of the superior laryngeal nerve in esophageal reflexes. American journal of physiology. Gastrointestinal and liver physiology, 302 12:G1445-57, Jun 2012. URL: https://doi.org/10.1152/ajpgi.00007.2012, doi:10.1152/ajpgi.00007.2012. This article has 41 citations.